Skip to main content
IntroMedic Co., Ltd. logo

IntroMedic Co., Ltd. — Investor Relations & Filings

Ticker · 150840 ISIN · KR7150840007 KO Manufacturing
Open in API
Filings indexed 442 across all filing types
Latest filing 2019-01-16 Proxy Solicitation & In…
Country KR South Korea
Listing KO 150840

About IntroMedic Co., Ltd.

http://www.intromedic.com/

IntroMedic Co., Ltd. is a medical device company that develops, manufactures, and distributes capsule endoscopy products. Established in 2004, the company's core offering is the MiroCam® capsule endoscope system. This system is designed as a tool for the detection of abnormalities within the small bowel in both adult and pediatric patients from two years of age. IntroMedic operates through a global network of partner companies to distribute its medical equipment.

Recent filings

Filing Released Lang Actions
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal 'Solicitation of Proxy' (의결권 대리행사의 권유) filed by Intromedic Co., Ltd. It outlines the purpose of the upcoming Extraordinary General Meeting (EGM), including agenda items such as amendments to the Articles of Incorporation and the appointment of directors. It provides details on the solicitor, the proxy solicitation period, and the specific proposals to be voted on by shareholders. This aligns perfectly with the definition of a Proxy Solicitation & Information Statement (PSI).
2019-01-16 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed in Korea. It details changes in share ownership by 'Synergy-Metistone New Technology Investment Fund' in the company 'Intromedic'. This type of filing is specifically used to notify the market and regulators when a shareholder's stake crosses significant thresholds or changes significantly, which corresponds to the 'Major Shareholding Notification' category.
2019-01-02 Korean
타법인주식및출자증권취득결정(자율공시)
Capital/Financing Update Classification · 95% confidence The document is a regulatory filing from a Korean company (IntroMedic) announcing the acquisition of shares in another corporation (Hyunjin Green Bio). This type of disclosure, specifically regarding 'Acquisition of Stocks and Securities of Other Corporations' (타법인주식및출자증권취득결정), is a standard corporate event announcement. Since it does not fit into specific categories like M&A (which usually implies a merger or takeover of the entity itself) or capital changes, and is a formal regulatory disclosure, it falls under the 'Regulatory Filings' (RNS) category.
2018-12-31 Korean
주요사항보고서(타법인주식및출자증권양도결정)
Share Issue/Capital Change Classification · 95% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Korea Exchange (KRX) regarding the decision to dispose of shares in another company (타법인 주식 및 출자증권 양도결정). This type of regulatory filing is a mandatory disclosure for material corporate events under the Capital Markets Act in South Korea. Since it does not fit into specific categories like M&A (which usually refers to business combinations/takeovers) or other specialized categories, it falls under the general regulatory filing category.
2018-12-31 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report of Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. It details the sale of shares by an executive (Shim Han Bo) of Intromedic. This type of filing, which reports personal share transactions by company directors and executives, is classified as 'Director's Dealing'.
2018-12-19 Korean
전환청구권행사(제4회차)
Capital/Financing Update Classification · 95% confidence The document is a regulatory filing from Intromedic regarding the exercise of conversion rights (전환청구권행사) for convertible bonds. This involves the issuance of new shares resulting from the conversion of debt into equity, which directly impacts the company's capital structure. According to the provided definitions, announcements regarding new share issues or capital changes fall under the 'SHA' category.
2018-12-19 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.